These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 224964

  • 1. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.
    Desgranges C, Lavoué MF, Patet J, de-Thé G.
    Biomedicine; 1979 Jun; 30(2):102-8. PubMed ID: 224964
    [Abstract] [Full Text] [Related]

  • 2. In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes.
    Desgranges C, Lenoir G, de-Thé G, Seigneurin JM, Hilgers J, Dubouch P.
    Biomedicine; 1976 Dec 05; 25(9):349-52. PubMed ID: 187263
    [Abstract] [Full Text] [Related]

  • 3. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD, Stewart JP, Arrand JR, Mackett M.
    Oncogene; 1995 Nov 02; 11(9):1711-9. PubMed ID: 7478598
    [Abstract] [Full Text] [Related]

  • 4. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T, Ogura H, Sato H, Umeda R, Hatano M.
    J Natl Cancer Inst; 1985 Jan 02; 74(1):57-60. PubMed ID: 2982054
    [Abstract] [Full Text] [Related]

  • 5. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D, Margalith M.
    Cancer Biochem Biophys; 1979 Jan 02; 3(4):157-62. PubMed ID: 233303
    [Abstract] [Full Text] [Related]

  • 6. Differences in expression of surface marker characteristics on Epstein-Barr virus-transformed human and simian lymphoid cell lines.
    Robinson JE, Andiman WA, Henderson E, Miller G.
    Primates Med; 1978 Jan 02; 10():149-55. PubMed ID: 205852
    [Abstract] [Full Text] [Related]

  • 7. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M.
    Hokkaido Igaku Zasshi; 1986 Jul 02; 61(4):584-92. PubMed ID: 3019855
    [Abstract] [Full Text] [Related]

  • 8. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M, Manor D, Agranat I, Bentor Y, Gelfand T, Goldblum N.
    Cancer Biochem Biophys; 1980 Jul 02; 4(3):137-43. PubMed ID: 6254633
    [Abstract] [Full Text] [Related]

  • 9. Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection.
    Alfieri C, Ghibu F, Joncas JH.
    Can Med Assoc J; 1984 Nov 15; 131(10):1249-52. PubMed ID: 6093976
    [Abstract] [Full Text] [Related]

  • 10. Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.
    Mackett M, Cox C, Pepper SD, Lees JF, Naylor BA, Wedderburn N, Arrand JR.
    J Med Virol; 1996 Nov 15; 50(3):263-71. PubMed ID: 8923292
    [Abstract] [Full Text] [Related]

  • 11. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
    Takimoto T, Sato H, Ogura H, Ogura T, Ishikawa S, Iwawaki J.
    ORL J Otorhinolaryngol Relat Spec; 1987 Nov 15; 49(4):169-74. PubMed ID: 2819802
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H, Takimoto T, Ogura H, Tanaka J, Hatano M, Glaser R.
    J Natl Cancer Inst; 1986 Jun 15; 76(6):1019-24. PubMed ID: 3012175
    [Abstract] [Full Text] [Related]

  • 13. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines.
    Lin CT, Chen W, Hsu MM, Dee AN.
    Lab Invest; 1997 Jun 15; 76(6):793-8. PubMed ID: 9194855
    [Abstract] [Full Text] [Related]

  • 14. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB, Montalvo EA, McClain KL, Ench Y, Heard P, Christy BA, Dewalt-Hagan PJ, Moyer MP.
    J Med Virol; 1999 Jan 15; 57(1):36-46. PubMed ID: 9890420
    [Abstract] [Full Text] [Related]

  • 15. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T, Nguyen QV, Woda B, Humphreys RE.
    J Immunol; 1987 Apr 15; 138(8):2645-52. PubMed ID: 2435803
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
    Guan M, Romano G, Henderson EE.
    Anticancer Res; 1999 Apr 15; 19(4B):3007-17. PubMed ID: 10652585
    [Abstract] [Full Text] [Related]

  • 17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J, Pai S, Cotter M, Robertson ES.
    Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337
    [Abstract] [Full Text] [Related]

  • 18. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A, Friedrichs C, Thust R, Wutzler P.
    Arch Virol; 2004 Jun 15; 149(6):1083-94. PubMed ID: 15168196
    [Abstract] [Full Text] [Related]

  • 19. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression].
    Jian SW, Mei CE, Liang YN, Li D, Chen QL, Luo HL, Li YQ, Cai TY.
    Ai Zheng; 2003 Jan 15; 22(1):26-9. PubMed ID: 12561431
    [Abstract] [Full Text] [Related]

  • 20. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT, Bluestein HG, Zvaifler NJ.
    J Immunol; 1985 Apr 15; 134(4):2287-93. PubMed ID: 2857749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.